HTTP/1.1 200 OK
Server: nginx
Date: Fri, 15 Nov 2024 03:47:50 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding
Link: <https://www.finepharma.co.bw/wp-json/>; rel="https://api.w.org/"
Link: <https://www.finepharma.co.bw/wp-json/wp/v2/pages/28>; rel="alternate"; type="application/json"
Link: <https://www.finepharma.co.bw/>; rel=shortlink
Vary: Accept-Encoding
Strict-Transport-Security: max-age=63072000; includeSubdomains;
SSL Certificate
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
4f:65:dd:0e:2b:b8:52:d8:75:c4:d5:c6:de:4a:28:46
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=GB, ST=Greater Manchester, L=Salford, O=Sectigo Limited, CN=Sectigo RSA Domain Validation Secure Server CA
Validity
Not Before: Jan 25 00:00:00 2024 GMT
Not After : Jan 25 23:59:59 2025 GMT
Subject: CN=finepharma.co.bw
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:d2:16:be:92:27:03:5e:ec:aa:fa:4c:cc:44:17:
3b:3d:34:88:3d:6b:9d:2f:0a:2b:79:c1:5b:51:f2:
80:42:e1:dc:96:ba:45:4c:fc:95:96:52:b2:b0:bc:
8c:d8:ba:b5:73:d0:14:1d:be:53:eb:52:5d:6b:83:
39:20:98:af:0e:47:9c:46:6e:72:80:41:4c:dc:84:
98:e9:a7:83:11:7d:7f:a4:a2:45:37:a2:9a:b1:ce:
74:66:9a:bb:8a:7d:c6:71:cd:03:d2:c7:c0:05:1b:
30:f0:b7:b3:77:fc:ff:0f:51:a7:06:84:4b:d3:d2:
00:fd:38:ad:89:2c:33:5c:6d:34:bb:58:33:32:5c:
54:1e:68:cf:65:22:77:63:05:ed:76:f8:d9:cb:64:
1a:e9:ff:a4:c2:05:8d:27:6a:cf:2a:b1:15:66:14:
9e:2d:59:fd:07:10:f5:bf:e6:35:d6:cd:9a:89:ba:
d6:59:f7:9d:81:b8:e9:7c:0c:81:36:1a:8c:32:ce:
c9:a5:00:8a:f7:9c:0f:50:ee:1c:e9:2b:ba:82:87:
1b:00:c1:c9:49:37:2d:2f:05:61:bc:af:b1:1a:93:
11:59:c3:7b:e8:51:9f:26:69:e2:57:ba:8b:74:33:
d7:25:9d:40:48:40:18:70:13:79:a9:ca:85:62:f9:
76:19
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Authority Key Identifier:
8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1
X509v3 Subject Key Identifier:
7B:25:80:AA:8B:53:18:CD:2B:BD:BF:32:25:85:7F:5A:D2:74:CE:3D
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Basic Constraints: critical
CA:FALSE
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Certificate Policies:
Policy: 1.3.6.1.4.1.6449.1.2.2.7
CPS: https://sectigo.com/CPS
Policy: 2.23.140.1.2.1
Authority Information Access:
CA Issuers - URI:http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt
OCSP - URI:http://ocsp.sectigo.com
X509v3 Subject Alternative Name:
DNS:finepharma.co.bw, DNS:www.finepharma.co.bw
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Jan 25 06:04:05.803 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:21:00:F5:F7:F2:BD:1C:F9:53:D9:D4:D3:CD:
C5:93:58:7D:BE:34:5A:E1:A6:D6:01:ED:2C:83:89:E7:
E8:12:CE:B0:5B:02:20:1A:85:12:4C:FE:C8:67:25:F4:
BA:EB:98:CD:32:81:3D:EA:6A:01:F3:80:6D:90:B8:9D:
57:59:8E:A5:B7:30:8D
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Jan 25 06:04:05.938 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:4D:08:AD:0E:FE:7F:50:70:12:F7:DE:36:
3B:72:71:7F:43:D0:82:22:A4:BB:CB:CE:33:BE:DA:FD:
05:CD:96:E3:02:21:00:8D:59:64:FD:68:66:BC:E6:DA:
BB:E2:F9:3A:EE:2A:5B:C2:42:19:BA:8C:5E:94:34:60:
1A:E2:F7:BB:AB:91:B8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 4E:75:A3:27:5C:9A:10:C3:38:5B:6C:D4:DF:3F:52:EB:
1D:F0:E0:8E:1B:8D:69:C0:B1:FA:64:B1:62:9A:39:DF
Timestamp : Jan 25 06:04:05.769 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:50:FA:6B:63:79:DA:DE:5D:29:C3:5A:07:
7F:C3:62:FC:D1:BA:1C:03:97:5B:04:EE:C7:77:5F:92:
8D:E0:29:93:02:20:48:1D:5C:41:1E:E8:57:C2:92:B7:
FA:DC:D3:DA:6C:3C:45:A4:3D:DB:10:68:12:56:F6:B5:
2B:FC:20:BE:04:19
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
11:6d:eb:bb:42:9a:75:27:6f:3a:ff:26:4a:16:97:40:f0:b6:
b7:8d:e4:14:e7:9f:11:bc:29:fa:e5:b5:9a:22:1d:89:f1:87:
bb:8f:d9:43:eb:fa:c3:b0:a5:ad:96:d5:29:87:c4:81:a8:18:
c4:50:66:56:9e:fa:b3:5b:0d:e0:d8:e8:e0:0c:57:20:ae:fc:
32:a8:54:46:66:a9:8e:6e:e4:51:ea:d0:c8:cc:d0:d6:15:eb:
8b:d1:60:59:9e:c5:b7:a5:22:dd:64:d6:c5:9b:01:65:c0:82:
e4:dd:af:6a:48:22:6a:b1:94:2d:ee:c6:0f:eb:4e:9f:22:44:
65:bf:2a:44:f6:04:0b:a2:e1:3f:83:63:3b:6f:95:06:99:55:
81:2e:18:34:30:8c:13:b6:15:ef:53:94:d8:bc:16:11:4f:0e:
0d:b0:86:9e:f4:5a:ac:e8:34:43:17:1d:3e:6e:24:96:ed:0c:
1b:a0:a2:50:bf:3d:68:ae:38:0b:f0:d3:9c:5a:1f:17:1b:fc:
99:90:87:df:6a:ff:52:13:c2:76:43:3b:39:fe:02:56:9d:9a:
88:a1:79:64:f7:78:37:dd:cf:95:4d:3e:79:aa:17:62:e1:1a:
c4:e5:6a:df:22:3e:9d:3b:17:d6:7f:38:e2:21:33:7e:ec:dc:
ba:1c:eb:e8